GrayMatters Health Expands FDA-Cleared PTSD Treatment
What You Should Know:
– GrayMatters Health (GMH), a pioneer in digital brain biomarker-based mental health treatments, is broadening patient access to its Prism for PTSD™ therapy.
– As the first FDA-cleared self-neuromodulation device for post-traumatic…
Continue Reading